The story in detail
Researchers combined measured step counts, brain imaging and follow-up cognitive assessments in older adults without evident cognitive impairment. Among those with elevated amyloid, greater activity was associated with slower tau accumulation and slower cognitive decline. The relationship was not explained by having less amyloid, suggesting that different parts of the disease process may behave differently.
The association levelled off around 5,001–7,500 daily steps in the analysis. That range is neither a personal prescription nor a proven prevention threshold. Participants were not randomly assigned to walking targets, so other differences between more and less active people could contribute. The findings provide a rationale for intervention trials, particularly in sedentary people at increased risk, rather than evidence that walking prevents Alzheimer’s disease.
Updated: 20 October 2026 · Study date: 03.11.2025
What was found?
Researchers followed 296 older adults who were cognitively normal at baseline. Among those with Alzheimer-related brain changes, more daily steps were associated with slower cognitive decline.
What does it mean?
The association levelled off around 5,001–7,500 steps, suggesting that research should look beyond a single 10,000-step target.
Limitations
This observational study does not prove walking prevents Alzheimer’s disease. These ranges are not a personal exercise prescription.
Sources and review scope
English adaptation of the reviewed Turkish edition. The translation preserves its study population, uncertainty and limitations. It is not an independent new study review. Translation checked: 20 October 2026.
Editorial expansion: 21.10.2026
Keep this story
Feedback to the editor
Only the editor can read this; it is not a public comment. Do not include personal health information.
Sign in to send feedback